Homebound’s Oscar Buzz Gets No Love: Are Makers Skimpin’ on the Hype Train?

Yo, Homebound, India’s big Oscar bet for 2026, is straight-up vibin’ with prestige, but its theatrical run is quieter than a ninja in flip-flops! Droppin’ on September 26, 2025, this Neeraj Ghaywan banger—starring Ishaan Khatter, Vishal Jethwa, and Janhvi Kapoor—slayed at Cannes with a nine-minute standing O and snagged second runner-up at TIFF’s People’s Choice. Backed by Karan Johar’s Dharma and Scorsese’s clout, it’s got all the makings of a global glow-up. But hold up—two days in (as of September 28, 2025, 1:17 PM IST), it’s only scraped ₹80 lakh nett on a measly 200-225 screens, with a Day 1 snooze of ₹29-30 lakh. Where’s the promo pizzazz? No trailer drops, no star-studded Insta reels, no Bigg Boss plugs—just crickets. Are Dharma and co. too spooked to splurge on this niche migrant-caste saga, scared it won’t rake in the moolah? Meanwhile, Ishaan and Janhvi could be global superstars if the makers crank the hype machine. Let’s unpack this Bollywood fumble in funky style!This ain’t your masala popcorn flick—Homebound dives deep, riffin’ off Basharat Peer’s 2020 essay on a migrant worker’s lockdown tragedy, mixin’ caste clashes and Muslim-targeted shade with raw, no-song grit. Critics are losin’ it—100% on Rotten Tomatoes, Anupama Chopra callin’ it a “stunner,” and Variety hypin’ Ishaan’s “endearing” edge and Janhvi’s rural realness. But X is buzzin’ with shade: one user’s yellin’ “disaster” at the ₹20-30 lakh opener, while another’s like, “This ain’t Jawan, it’s Cannes gold!” Dharma’s playin’ it safe, droppin’ it on 131 Delhi-NCR screens and 103 in Mumbai, bankin’ on word-of-mouth while sidesteppin’ a clash with their own Sunny Sanskari next week. Why so shy? The niche vibe—think Masaan meets Article 15—ain’t pullin’ multiplex crowds, and 11 CBFC cuts toned down the spicy bits, maybe spookin’ the hype budget.Makers seem shook about recovery. With a tiny budget (unconfirmed, but festival-lean), ₹80 lakh in two days is grim—Khatter’s worst since Dhadak’s ₹8.71 crore opener, and Janhvi’s outdone by Dhadak 2. Telugu beast They Call Him OG stole ₹104 crore same weekend, leavin’ Homebound in the dust. A Mumbai premiere flexed Hrithik and Vicky Kaushal, and Janhvi’s Sridevi-inspired saree went viral, but no pan-India promo tour? Nada. X’s quiet too—pre-release hype fizzled, with “flop” taunts drownin’ out praise. Bet’s on Netflix (November 2025 drop) for global views, banking on Oscar shortlist vibes by December 16.But yo, Ishaan and Janhvi could slay globally! Their raw, no-filter roles scream breakout—think Vicky Kaushal post-Masaan. Scorsese’s nod and Cannes heat could land them Hollywood gigs, but only if Dharma drops serious coin on ads—diaspora screenings, Emmy-style campaigns, the works. A nomination (January 22, 2026 reveal) could spark a Lagaan-style rerun, maybe ₹50 crore global. Skimpin’ now risks buryin’ a gem—trade folks say a promo push could’ve hit ₹5-10 crore Week 1. So, what’s good? Let Homebound shine or let it Netflix-and-chill? Drop your vibe—hype it or skip it?

 

Deemak’s Global Gamble: Can Pakistan’s Horror Hit Overcome Cultural Constraints?

Pakistan’s supernatural thriller Deemak, a standout hit since its Eid al-Adha release on June 6, 2025, has smashed domestic records with PKR 17.5 crore (about $620,000), becoming the country’s highest-grossing horror film. Directed by Rafay Rashdi and starring Faysal Quraishi and Sonya Hussyn, its mix of jinn-infused folklore and saas-bahu family drama fueled a strong local run, pulling PKR 70 million in its opening weekend. With an international rollout set for October 17, 2025, across the UK, US, Canada, EU, and GCC, Deemak banks on its hybrid horror-drama appeal to match global successes like Hereditary or The Conjuring. However, your point about the "lack of sex" as a potential dampener highlights a key challenge in a global market where horror often leans on sensuality or bold themes to hook audiences. Will Deemak’s culturally restrained approach—rooted in Pakistan’s conservative norms—hinder its overseas potential?Domestic Strength vs. Global ExpectationsDeemak’s domestic dominance stems from its relatable family tensions and atmospheric scares, with VFX by Canada’s Imagine Magic FX earning praise despite a “weaker” climax. Its Best Editing win at the Shanghai Cooperation Organization Film Festival adds global cred. On X, fans laud its “bone-chilling” vibe, though some call its pacing “boring.” Unlike Bollywood’s occasional risqué horror (e.g., Ragini MMS 2’s erotic edge), Deemak avoids sexual content, aligning with Pakistan’s censor board strictures and cultural distaste for explicitness. This restraint resonated locally, where family audiences flocked to its emotional core, but overseas, horror thrives on bolder elements—sex, gore, or taboo themes.The “Lack of Sex” Factor AbroadGlobal horror often uses sensuality as a draw: It Follows (2014) tied sex to its curse, grossing $23M worldwide; Jennifer’s Body (2009) banked on Megan Fox’s allure for $31M. Even South Asian hits like India’s Tumbbad (2018) used suggestive imagery to amplify dread, earning $10M+ overseas. Deemak’s chaste approach—focusing on jinn hauntings and mother-in-law conflicts—may feel tame to Western or even diaspora audiences expecting edgier thrills. Pakistani cinema’s conservative lens (no on-screen intimacy, per Censor Board norms) limits its ability to compete with Hollywood’s provocative horror or Bollywood’s occasional sensual detours. On X, a user noted, “Deemak’s scares are solid, but it’s too ‘sanskari’ for international horror fans craving spice.”Can the Hybrid Formula Compensate?Deemak’s strength lies in its hybrid appeal: folklore-driven horror woven with universal family trauma, akin to The Babadook’s grief-laden scares ($10M global). Its diaspora-friendly narrative could pull 5M+ Pakistanis in the UK, US, Canada, and GCC, where cultural resonance trumps the need for sex. Director Rashdi pitches it as a “cultural export” with universal appeal, and its festival buzz could draw arthouse crowds. Yet, competition looms—October’s Joker: Folie à Deux and Venom 3 dominate screens, and Deemak’s Urdu/English mix needs subtitles for non-desi viewers, potentially alienating mainstream fans seeking instant thrills.

Factor	Bullish Case (Overcoming Constraints)	Bearish Case (Sex as a Dealbreaker)
Appeal	Family drama and jinn folklore offer fresh, culturally rich scares; diaspora draw (2M+ in GCC alone) could hit $500K–$800K.	Lack of sensuality or bold themes risks seeming “safe” vs. Midsommar’s shock value; may cap mainstream appeal.
Market Fit	Emotional horror aligns with global hits (The Conjuring, $2B+); festival cred boosts indie vibe.	Western audiences may find it “too desi” or slow without sex/gore hooks; mixed X reviews flag pacing.
Distribution	UK/US/GCC rollout via FunAsia taps diaspora; OTT potential (Netflix loves global horror).	Limited screens vs. Hollywood giants; cultural gap may deter non-Pakistani viewers expecting Hereditary-style edge.

Verdict: A Niche Win, Not a BlockbusterThe lack of sexual content could indeed dampen Deemak’s appeal in markets where horror often doubles as a sensual thrill ride. However, its emotional depth and cultural novelty give it a fighting chance, especially among diaspora audiences and festival circuits. A modest $300K–$800K overseas haul is likely, with potential for more if it lands OTT deals or viral buzz. It won’t outgross Maula Jatt’s $14M global run but could outshine prior Pakistani horror exports like Zibahkhana. For Pakistan’s cinema, it’s a bold step—less spicy, but hauntingly unique. Will its family chills outweigh the missing sizzle for you?